FDA Inspection
University Of Texas MD Anderson Cancer CenterUniversity Of Texas MD Anderson Cancer Center – FDA Inspection, Nov 1, 2013
Record Details
This FDA Inspection record concerns University Of Texas MD Anderson Cancer Center, with an inspection on November 1, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- November 1, 2013
- Product Type
- Biologics
View Company Profile
ID · cac7dfd6-2d3e-4a5c-ba0e-66e37835ff32
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 853820
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of University Of Texas MD Anderson Cancer Center
9| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 22, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 19, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 27, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 17, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for University Of Texas MD Anderson Cancer Center
- FDA Inspection 1270526 - 2025-09-18
- FDA Inspection 1220144 - 2023-09-22
- FDA Inspection 1122418 - 2020-03-19
- FDA Inspection 1064728 - 2018-08-27
- FDA Inspection 960316 - 2016-02-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.